Friday, September 04, 2015 3:48:27 AM
Your response: "How do you figure the market ignored ODD, B P3, and P P2 news. Stock was up a buck and climbing the day P P2 PR was released..."
The first event that you identify (ODD) was reported on 7/15.....on 7/14 the stock had closed at 2.64. Announcements on B P3, B-OM P2, and P P2 were made between 7/15 and 8/6.....the pps peaked at 2.57 ("climbing" from the 2.44 open) on the day the P P2 was released ahead of the 10:30AM 8/6 release of the SA thing.
The fact that the price during the period of the company releases started at 2.64, rose to 3.54, then dropped back to 2.57 prior to the "hit piece" seems to me to define "ignores any good news" pretty well (I realize that I'm ignoring the effect that any short selling ahead of the piece may have had.
In the first week of the year the share price was $4.30-4.50. The move down from 4.30-4.50 to 2.57 defines "ignores any good news" even better. I don't think that there was anything that could be described as definitively bad news during that 8 month period, so I would think it would be safe to conclude that whatever could be described as good news was ignored, no?
http://ih.advfn.com/stock-market/USOTC/cellceutix-corp-CTIX/historical
“I have had a wonderful time but this wasn't it.”
..........Groucho
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM